Celmatix Therapeutics Information
Contact top employees from
Celmatix Therapeutics
Summary
Celmatix Therapeutics is a private company that has been in the industry for 16 years. The company currently specializes in the Biotechnology, Health Care Services areas. The position of the Founder & CEO is occupied by Piraye Yurttas Beim. Its headquarters is located at New York, New York, USA. The number of employees ranges from 25 to 100. The annual revenue of Celmatix Therapeutics varies between 5.0M and 25M. Total funding of the company - $20.4M. To connect with Celmatix Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
Reproductive Biology and Medicine, Genomics, Bioinformatics, Biotech, Women's health, Drug Development
SIC Code
8000
DMA Code
New York Metropolitan Area
Founded
2009
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact Celmatix Therapeutics
Organization Website
Social Links
Phone Number
646-315-6622, +1 646 389 0245
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2012 | Privately Held | 100 - 250 | 20M | $23.3M | |
| 2011 | Privately Held | 25 - 100 | 17.4M | $13.1M | |
| 2015 | Privately Held | 25 - 100 | 4M | $15.3M | |
| 2015 | Public Company | 100 - 250 | 3.4M | $249.3M | |
| 2011 | Public Company | 25 - 100 | < 1M | $140.4M | |
| 2007 | Public Company | 100 - 250 | 100.6M | $470.2M | |
| 1987 | Public Company | 500 - 1.0K | 928.5M | $2.3B | |
| 1991 | Privately Held | 25 - 100 | 16M | $0 | |
| 1997 | Public Company | 25 - 100 | 9.9M | $0 | |
| 2004 | Privately Held | 1000-5000 | - | $- | |
| 2013 | Public Company | 100-200 | - | $- | |
| 2008 | - | 500-1000 | - | $- | |
| 2013 | - | 10-50 | - | $- | |
| 2008 | - | 500-1000 | - | $- | |
| 1987 | - | 1000-5000 | - | $- | |
| 2007 | - | 100-200 | - | $- | |
| 2011 | - | 10-50 | - | $- | |
| 2011 | - | 500-1000 | - | $- | |
| - | - | 10000+ | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Celmatix Therapeutics shows a diverse range of experience levels:
4% for 1–2 years9% for 3–4 years17% for 5–7 years43% for 8–10 years26% have over 11 years of service at Celmatix TherapeuticsContact top employees from
Celmatix Therapeutics
Caterina Clementi
Vice President of Biological Sciences
Geneviève Galarneau
Statistical Genetics Lead
Jennifer Winick
General Counsel
Anthony Chang
Platform Engineer
Todd Gehman
Director of Engineering
Elizabeth Amador
Director of Clinical Research Operations
Mark Adams
Chief Information Officer
Richard Hofbauer
COO
Teeba Jihad
Biointerpretation Research Intern
Madeline Richey
Research Associate
Qianyi Zhang
Data Scientist
Anja Zgodic
Data Scientist
Karen Hunter Cohn
Scientific Advisor
Haoyu Wang
Bioinformatics Intern
Charlotte Frank Sage
VP, Clinical Research Operations / R&D, SPM
Rebecca Urbelis
Product Advisor
Omar Palomino Sandoval
Senior FullStack RoR Developer on behalf of South Geeks
Herman Lau
Sr. System Administrator
Craig Bolton
General Counsel
Catherine Romanov
Shareholder
Brenda Frederick
Biomedical Engineer
Jayla Veccio
Public Relations Directory
Company Employee
Strategic Advisor
Company Employee
Electricista
Similar Companies
FAQ
Celmatix Therapeutics operates in the Biotechnology industries. More details can be found on the official website: celmatix.com.
The headquarters of Celmatix Therapeutics are located in New York, United States.
The current CEO of Celmatix Therapeutics is Piraye Yurttas Beim
You can contact Celmatix Therapeutics by phone at 646-315-6622, +1 646 389 0245.
Celmatix Therapeutics currently employs 10-50 people.
Celmatix Therapeutics's revenue is approximately 22M.
Well-known competitors of Celmatix Therapeutics include Ovia Health by Labcorp, Recombine, Extend Fertility and Evofem Biosciences.
